Skip to main content

74M CHF HTN DM PROSTATE CA

 

74 male from jalalpuram came with complaints of sob and chest pain since 3 days 

Patient was born and brought up in jalalpuram,lived along with parents and 3 siblings,studies till 9th standard,no health issues in childhood, discontinued education and entered carpenter work at 16 yrs of age.

He got married at age of 21 years and had 3 sons and 1 daughter and lead a relatively healthy life,

Patient remained asymptomatic till 14 years ago then he developed tingling sensation and weakness of limbs intermittently for which he went to local hospital and was diagnosed of having high blood pressures around 200/100 and was started on anti hypertensives,he was continuing medication and his bp was under control and remained asymptomatics until 7 yrs ago,

At that time he had h/o burning micturition along with pain and dribbling of urine ,he went to local hospital for that and was diagnosed of having prostatic carcinoma and resection of tumor was done at that time and also used medication for 2 years,in between he went to warangal as he was unsatisfied with the treatment of doctors there and went to warangal for further treatment as the symptoms like polyuria,burning micturition persisted even after surgery,there he was found to have recurrence of prostatic carcinoma and placed him on medical management,

Since then he was on medication for carcinoma and hypertension,

2 months ago patient developed weakness of limbs for which he went to hospital and found to have high blood sugars and was started on oral hypoglycemics,during that time he had itching over limbs and accidentally ruptured a nodule on his leg and undervent surgical procedure to close that wound

And discharged after 7 days.Since then he was worried about his health and as his financial conditions becoming worse he felt some what tensed and depressed and stopped taking medications for prostatic cancer,

Since 1 month patient noticed that he is having sob and intermittent chest pain while doing sternous work and while lifiting weights,

Sob and chest pain aggrevated since past 3-4 days for which he was brought to casuality by his attenders

No addictions

No significant family history

PHENOTYPE

Mid arm circumference- 30cms

Waist circumference- 82cms

Abdominal circumference- 87cms

Hip circumference-92cms

CHEST X-RAY PA VIEW

ECG

USH


2D ECHO





*DIAGNOSIS*

HEART FAILURE WITH REDUCED EJECTION FRACTION
HTN
DM


Discharge summary;

:74 Years/Male

Admission Date: 10/06/2024 09:29 AM

Diagnosis

1)HEART FAILURE SECONDARY TO CAD/CAD AKINETIC RCA,LCX HYPOKINETIC WITH REDUCED EF (32%)

2)ATRIAL FIBRILLATION

K/C/O HTN SINCE 5 YEARS ; DM2 5 MONTHS
S/PB/ORCHIODECTOMY

CASTRATION RESISTENT PROSTATE CARCINOMA 5 YEARS 

Case History and Clinical Findings

CHIEF COMPLAINTS:

SHORTNESS OF BREATH SINCE 1 WEEKCHEST PAIN SINCE 1 WEEK

HISTORY OF PRESENT ILLNESS:

PATIENT WAS APPARENTLY AASYMPTOMATIC 1 WEEK BACK THEN HE DEVELOPEDDIFFICULTY IN BREATHEING SINCE 1 WEEK ASSOCIATEWD WITH ORTHOPNEA PNDSWEATING GIDDINESS .
PATIENT COMPLAINTS OF CHEST TIGHTNESS CHEST PAINPATIENT HAS NO H/O INVOLUNTARY MOVEMENTS
NO H/O ABDOMINAL PAIN
H/O NOCTURIA 5-6 TIMES AT NIGHTPAST HISTORY:
K/C/O DM SINCE 3 MONTHS

 HTN SINCE 5 YEARS


PERSONAL HISTORY :
DIET - MIEDAPPETITE - NORMALSLEEP - ADEQUATE
BOWEL& BLADDER MOVEMENTS - REGULAR AND NOCTURIAADDICTIONS - NIL

GENERAL PHYSICAL EXAMINATION :
PATIENT IS CONSCIOUS , COHERENT &COOPERATIVE , WELL ORIENTED TO TIME ANDPLACE .
NO PALLOR/ ICTERUS / CYANOSIS / CLUBBING / LYMPHADENOPATHY / OEDEMA.VITALS :
BP ; 140/70MM HGPR : 84 BPM
RR : 20CPMTEMP ; 98FSPO2:94@RA
GEBS- 137 MG/ DL


SYSTEMIC EXAMINATION :


CNS :NFNDREFLEXESB T S K A
R +2 +2 + 1 +2 +1
L +2 +2 +1 +2 +1


CVS :
S1, S2 HEARD , NO MURMURS


RS :


BAE + , NVBS
ADVENTITIOUS SOUNDS : CREPTS PRESENT


P/A :
SOFT , NON TENDER


COURSE IN THE HOSPITAL :
74Y OLD MALE CAME TO CASUALITY WITH C/O SHORTNESS OF BREATH SINCE 1 WEEK
.CHEST PAIN SINCE 1 WEEK .ALL NECESSARY INVESTIGATIONS WERE SENT .PATIENT WASDIAGNOSED TO1)HEART FAILURE SECONDARY TO CAD/CAD AKINETIC ,RCA,LCXHYPOKINETIC WITH REDUCED EF (32%) 2)ARTERIAL FIBRILLATION 3)K/C/O HTN SINCE 5YEARS ; K/C/O DM2 SINCE 5 MONTHS 4)S/P B/L ORCHIODECTOMY SECONDARY TOCASTRATION RESISTENT PROSTATE CARCINOMA 5 YEARS AGO. K/C/O DM SINCE 3MONTHS .PATIENT WAS TREATED CONSERVATIVELY WITHTAB.ECOSPRIN,TAB.DABIGATRAN,TAB.DIGOXIN,TAB.VYMADA,TAB.GLIMI-M1,SYPPOTKLOR,SYP.CREMAFFIN PLUS AND INJ AUGMENTIN AND INJ.METROGYL AND TAB MET-XL AND ACCORDINGLY .PATIENT IS BEING DISCHARGED IN A HEMODYNAMICALLY STABLECONDITION .
Investigation
Name Value Range
Name Value RangePOST LUNCH BLOOD SUGAR 10-06-2024 10:46:AM 138 mg/dl 140-0 mg/dlRFT10-06-202410:46:AMUREA24mg/dl50-17mg/dlCREATININE0.8mg/dl1.3-0.8mg/dlURIC
ACID 2.0 mmol/L 7.2-3.5 mmol/LCALCIUM 10.0 mg/dl 10.2-8.6 mg/dlPHOSPHOROUS 3.4 mg/dl 4.5-
2.5 mg/dlSODIUM 138 mmol/L 145-136 mmol/LPOTASSIUM 3.4 mmol/L. 5.1-3.5 mmol/L.CHLORIDE99 mmol/L 98-107 mmol/LLIVER FUNCTION TEST (LFT) 10-06-2024 10:46:AMTotal Bilurubin 2.90mg/dl 1-0 mg/dlDirect Bilurubin 0.58 mg/dl 0.2-0.0 mg/dlSGOT(AST) 38 IU/L 35-0 IU/LSGPT(ALT) 35IU/L 45-0 IU/LALKALINE PHOSPHATASE 103 IU/L 119-56 IU/LTOTAL PROTEINS 6.4 gm/dl 8.3-6.4gm/dlALBUMIN 4.1 gm/dl 4.6-3.2 gm/dlA/G RATIO 1.82
COMPLETE URINE EXAMINATION (CUE) 10-06-2024 10:46:AMCOLOUR PaleyellowAPPEARANCE ClearREACTION AcidicSP.GRAVITY 1.010ALBUMIN NilSUGAR NilBILESALTS NilBILE PIGMENTS NilPUS CELLS 2-3EPITHELIAL CELLS 2-3RED BLOOD CELLSNilCRYSTALSNilCASTSNilAMORPHOUSDEPOSITSAbsentOTHERSNilHBsAg-RAPID10-06-
2024 10:46:AM Negative
Anti HCV Antibodies - RAPID 10-06-2024 10:46:AM Non ReactiveSERUM ELECTROLYTES (Na, K,C l) 11-06-2024 05:21:AMSODIUM 138 mmol/L 145-136 mmol/LPOTASSIUM 3.3 mmol/L 5.1-3.5
mmol/LCHLORIDE 98 mmol/L 98-107 mmol/L


SERUM ELECTROLYTES (Na, K, C l) 11-06-2024 10:37:PMSODIUM 140 mmol/L 145-136
mmol/LPOTASSIUM 3.0 mmol/L 5.1-3.5 mmol/LCHLORIDE 98 mmol/L 98-107 mmol/LRFT 12-06-
2024 10:46:PMUREA 45 mg/dl 50-17 mg/dlCREATININE 0.9 mg/dl 1.3-0.8 mg/dlURIC ACID 3.9
mmol/L 7.2-3.5 mmol/LCALCIUM 9.8 mg/dl 10.2-8.6 mg/dlPHOSPHOROUS 4.0 mg/dl 4.5-2.5
mg/dlSODIUM 137 mmol/L 145-136 mmol/LPOTASSIUM 3.1 mmol/L. 5.1-3.5 mmol/L.CHLORIDE 99
mmol/L 98-107 mmol/L
Treatment Given(Enter only Generic Name)
FLUID RESTRICTION <1.5L/DAY
SALT RESTRICTION <2.5 GM/DL
INJ.LASIX 100MG IN 50 ML NS @5ML./HR
INJ.LASIX 40MG IV/OD
INJ.HAI S/C TID
TAB.TELMISARTAN 40MG PO/OD
TAB.MET-XL 25MG PO/OD
TAB.ECOSPRIN GOLD (75/75/20) PO/HS
TAB.ABIRATERONE 500MG PO/OD
TAB.VYMADA 50MG PO/OD
SYP CREMAFFIN PLUS 15ML PO/STAT
TAB.WYSOLONE 5MG PO/OD
TAB.DIGOXIN 0.25 MG PO/OD
TAB.DABIGATRAN 110MG PO/BD
TAB.GLIMI -M1 PO/BD
SYP POTKLOR 15ML IN 100 ML WATER PO/TID
ZENFLOX - OZ PO/BD
Advice at Discharge
1.FLUID RESTRICTION <1.5L/DAY2.SALT RESTRICTION <2.5 GM/DL3.TAB . GLIMI M1PO/OD6.TAB.TELMISARTAN 40MG PO/OD7.TAB.MET-XL 25MG PO/OD8.TAB.ECOSPRIN GOLD(75/75/20) PO/HS9.TAB.VYMADA 50MG PO/OD10.SYP CREMAFFIN PLUS 15MLPO/STAT11.TAB.WYSOLONE 5MG PO/OD14.TAB.DIGOXIN 0.25 MGPO/OD15.TAB.DABIGATRAN 110MG PO/BD16.SYP POTKLOR 15ML IN 100 ML WATER PO/TIDX5 DAYS17. TAB ZENFLOX - OZ PO/BD X 5 DAYS


Comments

Popular posts from this blog

PROJECT

TITLE:-   BIOPSYCHOSOCIAL FACTORS INFLUENCING OUTCOMES IN PATIENTS WITH ABDOMINAL OBESITY AND MULTISYSTEM COMORBIDITIES  By Dr. VEMULAPALLI HIMAJA (General Medicine PG) Team Members- Dr. Rakesh Biswas(MD General Medicine), Dr.Vishwak (MD PSYCHIATRY) INTRODUCTION Abdominal obesity may be defined as excess deposits of fat in the abdominal region. It is a common health condition seen in South Asians and is positively related to non-communicable diseases (NCDs). It is independent of body mass index and measured by raised waist circumference for men≥90 cm and women≥80 cm1 Waist circumference (WC) and waist-to-hip ratio (WHR) are widely used as indirect measures of abdominal or central adiposity in epidemiological studies. Although the definition of abdominal obesity remains in dispute, the cutoffs for WC (102 cm for men, 88 cm for women) and WHR (0.95 for men, 0.88 for women) were recommended by the American Heart Association and the US Department of Agriculture2 Abdominal obesity ...

Participatory medicine

 Reflecting on my experiences as a patient advocate and a physician, I’ve seen both the strengths and the shortcomings of participatory medicine in action. Each patient’s journey has been unique, with moments of progress and empowerment, but also instances of struggle, especially when navigating issues like privacy, confidentiality, and security. The Good One of the most rewarding aspects of participatory medicine is seeing patients and their families become actively involved in care. For example, in the case of the 65-year-old man with chronic vomiting, there was a clear effort to include the patient in discussions about his symptoms and potential diagnoses. This active participation helped foster trust and engagement, even though the diagnostic journey was long. In chronic conditions like HFpEF and CKD, I’ve seen how educating patients about their disease helps them feel more in control. It’s encouraging to witness patients taking ownership of their health by asking questions and...

86M HTN DM CVA ORBITAL CELLULITIS SEPSIS

  86 year male born in a middle class family of 7 children, was an elder son, did not go to school and took upon family responsibility at a very young age and started fish business. He used to travel often inter country for his business. Can speak Hindi and Telugu.  Childhood was pleasant, married at young age and had five sons. His parents expired due to old age.  Patient started consuming alcohol (beer) during travelling occasionally and also started smoking. 16 years ago patient had complains of lower back pain and decreased urine output, went to Kamineni Hyderabad and was diagnosed as renal calculi and operated for same.  Two years later he returned home from work, had dinner and went to bed. Early in the morning he felt tiredness and struggled to wake up, later he observed he had right upper and lower limb weakness and slurring of speech. Patient went to local hospital and was diagnosed as right hemiparesis . At the same time he was also diagnosed with hypertens...